Advances in developing tris(8-quinolinolato)gallium(iii) as an anticancer drug: critical appraisal and prospects
Abstract
Gallium-based anticancer chemotherapeutics are appreciably progressing in clinical studies. A steady interest of
Maintenance work is planned from 09:00 BST to 12:00 BST on Saturday 28th September 2024.
During this time the performance of our website may be affected - searches may run slowly, some pages may be temporarily unavailable, and you may be unable to access content. If this happens, please try refreshing your web browser or try waiting two to three minutes before trying again.
We apologise for any inconvenience this might cause and thank you for your patience.
* Corresponding authors
a
Vernadsky Institute of Geochemistry and Analytical Chemistry, Russian Academy of Sciences, Kosygin St. 19, Moscow, Russia
E-mail:
andrei.timerbaev@univie.ac.at
Gallium-based anticancer chemotherapeutics are appreciably progressing in clinical studies. A steady interest of
Fetching data from CrossRef.
This may take some time to load.
Loading related content